Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7451 p545
12 May 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Pharmacists should screen for diabetes risk

Pharmacists are being encouraged to identify people at high risk of developing type 2 diabetes in a consensus statement published by the International Diabetes Federation.

The statement recommends using a simple check list for risk factors, including central obesity, family history of diabetes, cardiovascular history, diabetes during pregnancy and treatment with drugs known to increase diabetes, including glucocorticoids, beta-adrenergic antagonists and thiazides.

People considered at high risk should then be advised to have their plasma glucose level measured. Those confirmed to be at risk should be prioritised for lifestyle interventions to prevent disease progression.

Shailen Rao, chairman of the Primary Care Pharmacists’ Association and previously head of medicines management and diabetes lead at Hillingdon Primary Care Trust, said: “Pharmacists are better placed than most health care professionals for this type of screening because they are based in the community and see many people who are not ill.” He added that pharmacists should aim to provide a “full circle” approach to diabetes care, supporting the medication needs of people already diagnosed with diabetes as well as helping to find those at risk.

Sir George Alberti, national director for emergency access and the UK representative on the consensus group, said: “This is one of the greatest public health challenges of the 21st century.”

He added: “Pharmacists can play a major role in screening those at risk.”

Back to Top


©The Pharmaceutical Journal